date: 2021-09-20T08:47:16Z
pdf:PDFVersion: 1.4
pdf:docinfo:title: The Microbiome Tumor Axis: How the Microbiome Could Contribute to Clonal Heterogeneity and Disease Outcome in Pancreatic Cancer
xmp:CreatorTool: Arbortext Advanced Print Publisher 10.0.1306/W Unicode
access_permission:can_print_degraded: true
subject: Pancreatic ductal adenocarcinoma (PDAC) is one of the most malignant cancers.
dc:format: application/pdf; version=1.4
pdf:docinfo:creator_tool: Arbortext Advanced Print Publisher 10.0.1306/W Unicode
access_permission:fill_in_form: true
pdf:encrypted: false
dc:title: The Microbiome Tumor Axis: How the Microbiome Could Contribute to Clonal Heterogeneity and Disease Outcome in Pancreatic Cancer
modified: 2021-09-20T08:47:16Z
cp:subject: Pancreatic ductal adenocarcinoma (PDAC) is one of the most malignant cancers.
pdf:docinfo:subject: Pancreatic ductal adenocarcinoma (PDAC) is one of the most malignant cancers.
pdf:docinfo:creator: Meghna Basu
meta:author: Lisa-Marie Philipp
meta:creation-date: 2021-09-20T08:27:38Z
created: 2021-09-20T08:27:38Z
access_permission:extract_for_accessibility: true
Creation-Date: 2021-09-20T08:27:38Z
Author: Lisa-Marie Philipp
producer: Acrobat Distiller 7.0 (Windows)
pdf:docinfo:producer: Acrobat Distiller 7.0 (Windows)
pdf:unmappedUnicodeCharsPerPage: 0
dc:description: Pancreatic ductal adenocarcinoma (PDAC) is one of the most malignant cancers.
Keywords: PDAC, microbiome, CSC, microbiome-targeted therapy, drug resistance, tumor heterogeneity, cancer stemness
access_permission:modify_annotations: true
dc:creator: Lisa-Marie Philipp
description: Pancreatic ductal adenocarcinoma (PDAC) is one of the most malignant cancers.
dcterms:created: 2021-09-20T08:27:38Z
Last-Modified: 2021-09-20T08:47:16Z
dcterms:modified: 2021-09-20T08:47:16Z
title: The Microbiome Tumor Axis: How the Microbiome Could Contribute to Clonal Heterogeneity and Disease Outcome in Pancreatic Cancer
xmpMM:DocumentID: uuid:539bfd06-5fb8-46f1-8496-8a58bfc1f643
Last-Save-Date: 2021-09-20T08:47:16Z
pdf:docinfo:keywords: PDAC, microbiome, CSC, microbiome-targeted therapy, drug resistance, tumor heterogeneity, cancer stemness
pdf:docinfo:modified: 2021-09-20T08:47:16Z
meta:save-date: 2021-09-20T08:47:16Z
Content-Type: application/pdf
X-Parsed-By: org.apache.tika.parser.DefaultParser
creator: Lisa-Marie Philipp
dc:subject: PDAC, microbiome, CSC, microbiome-targeted therapy, drug resistance, tumor heterogeneity, cancer stemness
access_permission:assemble_document: true
xmpTPg:NPages: 9
pdf:charsPerPage: 2636
access_permission:extract_content: true
access_permission:can_print: true
meta:keyword: PDAC, microbiome, CSC, microbiome-targeted therapy, drug resistance, tumor heterogeneity, cancer stemness
access_permission:can_modify: true
pdf:docinfo:created: 2021-09-20T08:27:38Z